Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic target
Researchers at The University of Texas MD Anderson Cancer Center discovered how a common genetic mutation in glioma changes DNA shape to promote tumor progression. This finding opens a new potential therapeutic target for patients with ATRX-mutant gliomas, offering hope for improved treatment strategies.
glioma brain cancer ATRX mutation DNA shape tumor progression
Linked Entities
Contributing Articles
STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
STAT News Health —
Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement Transcript
Seeking Alpha —
COMPASS Pathways plc (CMPS) Discusses Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile in Depression Transcript
Seeking Alpha —
Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b Transcript
Seeking Alpha —
STAT+: FDA approves Vera Therapeutics kidney disease treatment
STAT News Health —
Oberland pours up to $400M into MeiraGTx eye gene therapies
BioPharma Dive —
Marshawn Kneeland, Cowboys player who died by suicide at 24, diagnosed with CTE
Yahoo Sports —
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
BioPharma Dive —
New approach could expand CAR T therapy from blood cancers to solid tumors
Medical Xpress —
Vertex To Acquire Crinetics For ~$10bn - What Investors Should Know
Seeking Alpha —